National Survey Shows 1 In 10 Children Use Cough/Cold OTCs Each Week
This article was originally published in The Tan Sheet
A long-term study underscores possible risks from OTC pediatric cough/cold products and emphasizes the significance of FDA's ongoing review of the medicines' safety and efficacy for 2- to 11-year-old children
You may also be interested in...
A potential "reverse switch" of pediatric cough/cold OTC drugs to prescription status would not address concerns about efficacy or misuse of the products, the Consumer Healthcare Products Association says
FDA plans to revise monograph language for over-the-counter pediatric cough/cold products, but the agency is seeking input on some basic data questions first, indicating many steps will be taken before a rule can be finalized
An FDA working group conducting a review of OTC cough and cold medicines for 2- to 11-year-old children will make recommendations this spring on actions the agency should take concerning use of the products for that age group, Office of Nonprescription Products officials said Jan. 17